IMmortal Foundation co-founder and President, Leszek Burzynski, interviewed distinguished attorney and end-of-life advocate, Kathryn Tucker, about the use of the hallucinogenic drug, psilocybin, in treating end-of-life anxiety. Kathryn has closely followed recent research that demonstrates the efficacy of the drug in allaying extreme emotional discomfort in terminal patients, and for a majority of the drug’s recipients even leading to intense and long lasting spiritual experiences.